4th Cell Therapy for Autoimmune Disease Summit

The 4th Cell Therapy for Autoimmune Disease Summit is the premier industry forum uniting biopharma leaders, clinical innovators, and scientific pioneers dedicated to advancing the next generation of cell therapies for autoimmune diseases. As the field progresses beyond early proof-of-concept studies and begins to generate increasingly robust clinical data, organizations are shifting their focus toward the critical challenges that will determine long-term success. These include identifying optimal targets, improving clinical translation, enhancing manufacturing scalability, ensuring patient safety, navigating evolving regulatory pathways, and developing sustainable commercialization strategies.

Taking place December 1-3, 2026, in Philadelphia, the summit provides a unique opportunity for stakeholders across biotech, pharma, academia, translational research, and clinical development to come together and share lessons learned from the forefront of autoimmune cell therapy innovation. With increasing momentum behind cell-based approaches for autoimmune indications, attendees will gain practical insights into how leading organizations are overcoming development hurdles and positioning their programs for future success.

The agenda showcases the latest breakthroughs across a range of therapeutic modalities, including CAR-T, NK, Treg, MSC, and emerging in vivo cell therapy approaches. Expert speakers from organizations such as Artiva Biotherapeutics, Kite Pharma, Cabaletta Bio, Sail Biomedicines, Mesoblast, Orca Bio, and other leading innovators will present real-world case studies, clinical updates, and strategic perspectives. Discussions will focus on analyzing increasingly mature clinical datasets, expanding cell therapy applications beyond oncology, exploring novel targets beyond CD19, leveraging biomarkers and endpoints to optimize development, and creating scalable manufacturing and delivery strategies to bring therapies to larger patient populations.

In addition to its comprehensive scientific program, the summit offers extensive networking opportunities designed to foster collaboration across the autoimmune cell therapy community. Attendees will have the chance to connect with peers, potential partners, investors, solution providers, and key opinion leaders who are addressing similar scientific, clinical, operational, and commercial challenges. Through interactive roundtable discussions, dedicated networking sessions, and informal meetings, participants can exchange ideas, establish valuable partnerships, and build relationships that help accelerate the development and delivery of transformative cell therapies for patients living with autoimmune diseases.

To know more visit: https://ter.li/j0rhnmgf